|Articles|June 28, 2023

Are Nitrosamines a Concern for Biologic Manufacturers?

Author(s)SGS

This article provides an assessment of nitrosamine contamination specifically in biologics and contrasts the potential risks between these product types.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content